Amarin Corp Plc (AMRN)

[Biobillionair]

Great question, let's speculate the triglyceride form of EPA as the worse case senerio for Amarin.

What would be the barriers?
There's 16 of them listed in the OB that cover a product called Vascepa. Some patents even cover EPA blood levels;) Although the API would vary slightly from the Trigyleride EPA compared to the E-EPA the active moiety in both is EPA and EPA blood levels measured. Sounds like a great generic alternative to Icosapent Ethyl if AZN would like to wait for Amarin to go generic in 2030. AZN bought a generic product...the triglyceride form happens to be more expensive to make also.

Amarin's R&D patent team is all over this angle, can't comment further on this;)